Safety and Durability of Sirolimus for Treatment of LAM

NCT02432560 · clinicaltrials.gov ↗

RECRUITING

Status

600

Enrollment

OTHER

Sponsor class

Conditions

Lymphangioleiomyomatosis

Interventions

DRUG: Sirolimus
DRUG: Everolimus

Sponsor

University of Cincinnati

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]